| |
An Approach to Improve Diversity and Inclusion in Clinical Trials: The DEFINE Trial (D/C/F/TAF Evaluated As a Fixed-dose
Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain)
|
| |
| |
P O S T E R P R E S E N T E D AT H I V D A R T 2 0 2 0 ; D E C E M B E R 1 0 , 2 0 2 0 ; V I R T U A L M E E T I N G .
Reported by Jules Levin
Keith Dunn,1 Richard Bruce Simonson,1 Rachel Rogers,1 Purnima Kassam,1 Donghan Luo,2 Amanda Gibson,1 David Anderson1
1Janssen Scientific Affairs, LLC, Titusville, NJ; 2Janssen Research & Development, LLC, Titusville, NJ.
REFERENCES
1. Centers for Disease Control and Prevention. HIV among African Americans. https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/cdc-hiv-aa-508.pdf. Accessed November 4, 2020.
2. Centers for Disease Control and Prevention. HIV and women. https://www.cdc.gov/hiv/group/gender/women/index.html. Accessed November 4, 2020.
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf.
Accessed October 30, 2020.
4. Centers for Disease Control and Prevention. HIV surveillance report, 2018 (preliminary); volume 30. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed November 4, 2020.
5. Centers for Disease Control and Prevention. Adult obesity prevalence maps. https://www.cdc.gov/obesity/data/prevalence-maps.html. Accessed November 4, 2020.
|
|
| |
| |
|
|
|
